OUR LANDSCAPE
Product Portfolio: In partnership with ATHENA - one of the leaders in oral dispersible technology, we offer a range of innovative products developed using the Fastmelt® platform. This portfolio caters to patients with specific administration needs, enhancing medication intake and efficacy. Our joint venture in Dubai extends our reach, bringing these advanced solutions to the MENA region and beyond. (feel free to contact us for more details)
​
Market Research and Insights: Utilizing IQVIA data and insider healthcare provider information, we identify unmet needs and opportunities in our target markets. Our focus is on quick, receptive availability of EU CTD dossiers for local manufacturing partners in niche pharmaceutical sectors.
Competitive Landscape: While the market hosts various individual players, GlobalBridge Pharma B.V.’s unique business model and strategic plan set us apart. Our agile approach and robust network enable us to rapidly adapt to market changes, maintaining a competitive edge in evolving markets.
​
Growth and Expansion Plans: Short-term, we aim to register and launch 9 products (to be announced during Arab Health)in the UAE by 2024 and establish a trading platform in the Netherlands. Long-term, we remain flexible within our core services, ready to explore new opportunities as they arise.
​
Stakeholder Engagement: Leveraging the extensive networks of our team, we engage with key industry players and participate in major events like BIO EUROPE, CPHI, and Arab Health. This approach ensures continuous connection and promotion within the Life Science and Biotech community.
GLOBALBRIDGE PHARMA BV FEATURES
Strengthening Our Products
LOOKING FORWARD
Exceeding Expectations
GlobalBridge Pharma B.V. is committed to being a proactive catalyst for change in the pharmaceutical industries of our key geographies. By fostering collaborations and leveraging our expertise, we aim to make a lasting impact in improving Regional health outcomes and faster introduction of the unmet modern solutions and technologies as well as bridge B2B market access component and going-to-market Strategies.
TAILORED SOLUTION
Bringing You What Your Customers or Market Demand
We want to add value in every interaction thus the first question is always - what is required for you. We operate within B2B segment but Patients and Pharmacy/Distribution Chains are always what we are thinking first as the front end of the supply chain from sourcing the right molecule with the right form to serve the demand.
Our team and partners at GlobalBridge Pharma bring together a wealth of experience, with cumulative expertise spanning over decades in the 360-degree landscape of the Life Science supply chain. Our comprehensive knowledge covers every aspect from Research & Development to Go-To-Market strategies, encompassing pharmaceuticals, medical devices, disposables, aesthetics, lifestyle products, and digital medicine. We pride ourselves on our ability to serve as a one-stop solution for your specific projects, whether at the very early stages or during pilot project execution. We shape strategies and drive the execution, ensuring that your portfolios have the right product(s) which successfully reach the market with optimal impact. With our holistic approach and deep industry insights, GlobalBridge Pharma is dedicated to delivering practical solutions and achieving excellence in every project we undertake.